Postconditioning: from experimental proof to clinical concept
- PMID: 20075381
- DOI: 10.1242/dmm.004309
Postconditioning: from experimental proof to clinical concept
Abstract
The therapeutic strategies for acute myocardial infarction in the last decade have, among other therapeutic targets, focused on myocardial reperfusion injury, which accounts for a significant part of the final infarct size. Although several experiments in the last 20 years have reported that pharmacological interventions at reperfusion might reduce myocardial reperfusion injury, this could not be consistently confirmed in animal models or human studies. An alternative to chemical modifiers, postconditioning (brief repeated periods of ischemia applied at the onset of reperfusion) is the first method proven to be efficient in different animal models and to be confirmed in a recent human study. This simple method, applied in the first minute of reperfusion, reduces the final infarct size by 30-50%. This review will focus on the postconditioning technique and show how the data from different animal models and experimental settings have advanced our understanding of both the mechanisms and the definition of an accurate protocol that is easily applicable in human patients in the setting of acute myocardial infarction.
Similar articles
-
Postconditioning: from the bench to bedside.J Cardiovasc Pharmacol Ther. 2011 Jun;16(2):117-30. doi: 10.1177/1074248410383174. Epub 2010 Oct 11. J Cardiovasc Pharmacol Ther. 2011. PMID: 20938041 Review.
-
[Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S76-101. Arch Cardiol Mex. 2006. PMID: 17469337 Review. Spanish.
-
Ischemic postconditioning: experimental models and protocol algorithms.Basic Res Cardiol. 2009 Sep;104(5):469-83. doi: 10.1007/s00395-009-0040-4. Epub 2009 Jun 19. Basic Res Cardiol. 2009. PMID: 19543787 Review.
-
Pharmacological targets revealed by myocardial postconditioning.Curr Opin Pharmacol. 2009 Apr;9(2):177-88. doi: 10.1016/j.coph.2008.11.009. Epub 2008 Dec 26. Curr Opin Pharmacol. 2009. PMID: 19109069 Review.
-
Postconditioning: reduction of reperfusion-induced injury.Cardiovasc Res. 2006 May 1;70(2):200-11. doi: 10.1016/j.cardiores.2006.01.024. Epub 2006 Mar 20. Cardiovasc Res. 2006. PMID: 16545349 Review.
Cited by
-
Phosphomimetic modulation of eNOS improves myocardial reperfusion and mimics cardiac postconditioning in mice.PLoS One. 2014 Jan 21;9(1):e85946. doi: 10.1371/journal.pone.0085946. eCollection 2014. PLoS One. 2014. PMID: 24465805 Free PMC article.
-
Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes.Antioxid Redox Signal. 2011 Mar 1;14(5):781-90. doi: 10.1089/ars.2010.3343. Epub 2010 Oct 6. Antioxid Redox Signal. 2011. PMID: 20578962 Free PMC article.
-
Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts.Pharmacol Res. 2011 Oct;64(4):381-92. doi: 10.1016/j.phrs.2011.06.018. Epub 2011 Jun 29. Pharmacol Res. 2011. PMID: 21741479 Free PMC article.
-
Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.Drugs Aging. 2011 May 1;28(5):331-43. doi: 10.2165/11587190-000000000-00000. Drugs Aging. 2011. PMID: 21542657 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources